lysine has been researched along with Chondrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TY; Lan, KC; Liu, SH; Sheu, ML; Wu, CH; Yang, RS | 1 |
| d'Arville, C; Hascall, VC; Kimura, JH; Mason, RM | 1 |
2 other study(ies) available for lysine and Chondrosarcoma
| Article | Year |
|---|---|
Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Topics: Animals; Chondrosarcoma; Diabetes Mellitus; Glycation End Products, Advanced; Glycogen Synthase Kinase 3; Humans; Hyperglycemia; Lysine; Mice; Mice, Inbred NOD; Mice, SCID | 2023 |
Absence of covalently linked core protein from newly synthesized hyaluronate.
Topics: Animals; Betaine; Cells, Cultured; Centrifugation, Density Gradient; Chondrosarcoma; Chromatography, Gel; Guanidine; Guanidines; Hyaluronic Acid; Hyaluronoglucosaminidase; Lysine; Quaternary Ammonium Compounds; Rats; Serine | 1982 |